Hims & Hers Health
Prix: 26.82Entreprise et modèle économique
Hims & Hers Health is a healthcare company that provides telehealth services and wellness products, focusing on personal health and wellness solutions. Its core offerings include prescription medications, over-the-counter products, and health consultations, primarily targeting issues such as sexual health, hair loss, and skincare. The company operates through direct-to-consumer channels, generating revenue from subscription services and product sales.
Profil d’investissement
The investment profile of Hims & Hers Health is more aligned with growth investors, given its focus on expanding its service offerings and market reach. The company currently does not provide dividends and has shown volatility in its earnings. Investors should consider the potential for future growth against the backdrop of higher risk factors.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- -0.05 Risque
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- -1.6% ≈
- Surprise BPA
- -550.0% moins bon que prévu
- Volatilité 20 j
- 4.6% stable
Impact de la prévision
neutreSuivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-05-30 02:41 | Conserver | Vendre | Weak fundamentals and high volatility raise significant concerns. |
| 2026-05-14 03:36 | Acheter | Conserver | Weak momentum and high risk; uncertain growth outlook. |
| 2026-05-10 02:33 | Conserver | Acheter | Strong momentum and positive EPS surprise indicate growth potential. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-06-02 12:19 | Leerink Partners | Mettre à jour | — → 25 | 27.635 |
| 2026-05-26 09:25 | UBS | Objectif abaissé | — → 25 | 23.75 |
| 2026-05-22 14:00 | UBS | Objectif relevé | 18 → 23 | 23.88 |
Rien pour le moment